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The chemotherapeutic agent temozolomide (TMZ) is commonly used in glioblastoma (GBM) 
therapy, but patients usually have a poor prognosis. Rutin, a citrus flavonoid ecglycoside found in 
edible plants, has neuroprotection and anticancer activities. This study aims to investigate the 
efficacy of rutin in combination with temozolomide and the underlying mechanisms. In vitro 
viability assay demonstrated that rutin alone had generally low cytotoxic effect, but it was able to 
enhance the efficacy of TMZ in a dose-dependent manner. An in vivo xenograft study also 
showed that tumor volumes were significantly decreased in mice under combination treatment as 
compared to TMZ alone. Moreover, western blot analysis showed that TMZ activated JNK 
activity to induce protective response autophagy, while rutin blocked JNK activation, resulting in 
decreased autophagy and increased apoptosis, suggesting that rutin enhances TMZ efficacy via 
inhibition of JNK-mediated autophagy. Overall, these results indicate that the combination rutin 
with TMZ could improve the therapeutic efficacy of GBM. 
